WilliamTCarpenterMD
Psychiatry • Baltimore, MDProfessor, Psychiatry, University of Maryland School of Medicine
Dr. Carpenter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
PO Box 21247
Maryland Psychiatric Research Center
Baltimore, MD 21228Phone+1 410-402-7101
Education & Training
University of RochesterResidency, Psychiatry, 1963 - 1966
Wake Forest University Baptist Medical CenterInternship, Transitional Year, 1962 - 1963
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1962
Certifications & Licensure
MD State Medical License 1969 - 2024- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- Lifetime Achievement Award Schizophrenia International Research Society, 2019
- Pardes Humanitarian Prize Brain and Behavior Research Foundation, 2019
- Elected Member Institute of Medicine, 1998
Clinical Trials
- Adjunctive Treatment for Decreasing Symptoms of Schizophrenia Start of enrollment: 2000 Jan 01
- Effects of Oxytocin Nasal Spray on Social Affiliation Start of enrollment: 2009 Oct 01
- Oxytocin or Galantamine Versus Placebo for the Treatment of Negative Symptoms and Cognitive Impairments in Schizophrenia Start of enrollment: 2010 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsPsychosis superspectrum II: neurobiology, treatment, and implications.Roman Kotov, William T Carpenter, David C Cicero, Christoph U Correll, Elizabeth A Martin
Molecular Psychiatry. 2024-05-01 - 1 citationsPrecision psychiatry and Research Domain Criteria: Implications for clinical trials and future practice.Leanne M Williams, William T Carpenter, Carrie Carretta, Evangelos Papanastasiou, Uma Vaidyanathan
CNS Spectrums. 2024-02-01 - Categorical and Dimensional Approaches for Psychiatric Classification and Treatment Targeting: Considerations from Psychosis Biotypes.Brett A Clementz, Michal Assaf, John A Sweeney, Elliot S Gershon, Sarah K Keedy
Advances in Neurobiology. 2024-01-01
Press Mentions
Thomas Jobe: The Legacy of Research He Leaves BehindMarch 24th, 2022- Putting JAMA Psychiatry and MIA to the Genetic TestMarch 14th, 2024
Grant Support
- Operations And Clinical Assesment CoreNational Institute Of Mental Health2008–2011
- Centers For Intervention Development And Applied Research (CIDAR)National Institute Of Mental Health2008–2011
- Multidisciplinary Schizophrenia Research TrainingNational Institute Of Mental Health2005–2011
- A 3T Scanner For Establishing Um Mprc Neuroimaging Research FacilityNational Center For Research Resources2010
- Center For Intervention Development And Applied ResearchNational Institute Of Mental Health2009
- Research Ethics In SchizophreniaNational Institute Of Mental Health1999–2008
- Core--Research Methods CoreNational Institute Of Mental Health2003–2007
- Core--Principal Research CoreNational Institute Of Mental Health2003–2007
- Core--Operations CoreNational Institute Of Mental Health2003–2007
- BIOS. And Data Man.National Institute Of Mental Health2003–2007
- Glutamatergic Agents For The Treatment Of Negative SymptomsNational Center For Research Resources2005
- Research Ethics In SchizophreniaNational Center For Research Resources2004
- Glutamatergic Agents For Therapy Of SchizophreniaNational Center For Research Resources2004
- Advanced Centers For Interventions And Services ResearchNational Institute Of Mental Health2003–2004
- Treatment Of Negative Symptoms &Cognitive ImpairmentsNational Institute Of Mental Health2000–2003
- Irc--Classification And Course Of SchizophreniasNational Institute Of Mental Health1999–2002
- Scientific Support CoreNational Institute Of Mental Health1996–2002
- Patient And Subject Recruitment CoreNational Institute Of Mental Health1996–2002
- Crc--Classification And Course Of SchizophreniasNational Institute Of Mental Health1998
- Assessment CoreNational Institute Of Mental Health1996–1997
- Crc: Classification And Course Of The SchizophreniasNational Institute Of Mental Health1994–1997
- Outpatient Treatment--Targeted VS Maintenance MedicationNational Institute Of Mental Health1987–1996
- Crc--Classification And Course Of The SchizophreniasNational Institute Of Mental Health1993
- Neuroscience Center For Research In SchizophreniaNational Institute Of Mental Health1989–1993
- Crc: Classification And Course Of The SchizophreniasNational Institute Of Mental Health1987–1992
- Scientific And Technical Evaluation AwardNational Institute Of Mental Health1988–1990
- The Efficacy Of Carbamazepine In Psychiatric OutpatientsNational Institute Of Mental Health1987–1989
- Crc--Classification And Course Of The SchizophreniasNational Institute Of Mental Health1986
- Outpatient Treatment: Targeted VS Maintenance MedicationNational Institute Of Mental Health1985–1986
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
